JP Morgan Chase
IMMX icon

JP Morgan Chase’s Immix Biopharma IMMX Stock Holding History

JP Morgan Chase’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$205K Buy
19,575
+17,038
+672% +$158K ﹤0.01% 5603
2026
Q1 		$21.8K Sell
2,537
-2,572
-50% -$18.9K ﹤0.01% 6509
2025
Q4 		$26.7K Buy
+5,109
New +$21K ﹤0.01% 6439
2025
Q2 		– Sell
-35
Closed -$59 – 7361
2025
Q1 		$59 Sell
35
-3
-8% -$6 ﹤0.01% 6955
2024
Q4 		$84 Buy
+38
New +$69 ﹤0.01% 7037
2024
Q2 		– Sell
-9,039
Closed -$27.8K – 7554
2024
Q1 		$27.8K Buy
9,039
+8,361
+1,233% +$32.4K ﹤0.01% 6137
2023
Q4 		$4.69K Buy
678
+671
+9,586% +$3.04K ﹤0.01% 6563
2023
Q3 		$24 Buy
+7
New +$16 ﹤0.01% 7136

Other funds holding IMMX

JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase's IMMX Position: Q2 2026 in Review

JP Morgan Chase increased its Immix Biopharma (IMMX) stake by 672% in Q2 2026, buying an estimated $158K and bringing the position to 19,575 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #5603.

JP Morgan Chase first reported a position in IMMX in Q3 2023 and has held it in 8 quarters since. 109 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • JP Morgan Chase held 19,575 shares of Immix Biopharma worth $205K as of Q2 2026.
  • JP Morgan Chase bought 17,038 Immix Biopharma shares in Q2 2026, an estimated $158K.
  • Immix Biopharma made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5603 holding.
  • JP Morgan Chase first reported a position in Immix Biopharma in Q3 2023 and has held it in 8 quarters since.
  • 109 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.